Women’s perceptions about reducing the frequency of monthly bleeding: results from a multinational survey

References

• Shakespeare J, Neve E, Hodder K. Is norethisterone a lifestyle drug? Results of database analysis. BMJ. 2000;320(7230):291.
   PubMedGoogle Scholar
• Szarewski A. Sisters doing it for themselves. J Fam Plann Reprod Health Care. 2009;35(2):71–72.
   Google Scholar
• Thomas SL, Ellertson C. Nuisance or natural and healthy: should monthly menstruation be optional for women? Lancet. 2000;355(9207):922–924.
   PubMed Web of Science ®Google Scholar
• Loudon NB, Foxwell M, Potts DM, Guild AL, Short RV Acceptability of an oral contraceptive that reduces the frequency of menstruation: the tri-cycle pill regimen. Br Med J. 1977;2(6085):487–490.
   Google Scholar
• A cross-cultural study of menstruation: implications for contraceptive development and use. World Health Organization Task Force on Psychosocial Research in Family Planning, Special Programme of Research, Development and Research, Training in Human Reproduction. Stud Fam Plann. 1981;12(1):3–16.
   Google Scholar
• Rutter W, Knight C, Vizzard J, Mira M, Abraham S. Women’s attitudes to withdrawal bleeding and their knowledge and beliefs about the oral contraceptive pill. Med JAust. 1988;149(8):417–419.
   Google Scholar
• Wiegratz I, Hommel HH, Zimmermann T, Kuhl H. Attitude of German women and gynecologists towards long-cycle treatment with oral contraceptives. Contraception. 2004;69(1):37–42.
   PubMed Web of Science ®Google Scholar
• Glasier AF, Smith KB, van der Spuy ZM, et al. Amenorrhea associated with contraception-an international study on acceptability. Contraception. 2003;67(1):1–8.
   PubMed Web of Science ®Google Scholar
• Kaunitz AM. Menstruation: choosing whether ... and when. Contraception. 2000;62(6):277–284.
   PubMed Web of Science ®Google Scholar
• Szarewski A, von Stenglin A, Rybowski S. Women’s attitudes towards monthly bleeding: results of a global population-based survey. Eur J Contracept Reprod Health Care. 2012;17(4):270–283.
   PubMed Web of Science ®Google Scholar
• Anderson FD, Gibbons W, Portman D. Safety and efficacy of an extended-regimen oral contraceptive utilizing continuous low-dose ethinyl estradiol. Contraception. 2006;73(3):229–234.
   PubMed Web of Science ®Google Scholar
• Anderson FD, Hait H. A multicenter, randomized study of an extended cycle oral contraceptive. Contraception. 2003;68(2):89–96.
   PubMed Web of Science ®Google Scholar
• Archer DF, Jensen JT, Johnson JV, Borisute H, Grubb GS, Constantine GD. Evaluation of a continuous regimen of levonorgestrel/ ethinyl estradiol: phase 3 study results. Contraception. 2006;74(6):439–445.
   PubMed Web of Science ®Google Scholar
• Cachrimanidou AC, Hellberg D, Nilsson S, Waldenström U, Olsson SE, Sikström B. Long-interval treatment regimen with a desogestrel-containing oral contraceptive. Contraception. 1993;48(3):205–216.
   Web of Science ®Google Scholar
• Krishnan S, Kiley J. The lowest-dose, extended-cycle combined oral contraceptive pill with continuous ethinyl estradiol in the United States: a review of the literature on ethinyl estradiol 20 ag/levonorg- estrel 100 ag + ethinyl estradiol 10 ag. Int J Womens Health. 2010;2:235–239.
   Google Scholar
• Kroll R, Reape KZ, Margolis M. The efficacy and safety of a low-dose, 91-day, extended-regimen oral contraceptive with continuous ethinyl estradiol. Contraception. 2010;81(1):41–48.
   PubMed Web of Science ®Google Scholar
• Miller L, Notter KM. Menstrual reduction with extended use of combination oral contraceptive pills: randomized controlled trial. Obstet Gynecol. 2001;98(5 Pt 1):771–778.
   Web of Science ®Google Scholar
• Skouby SO. Contraceptive use and behavior in the 21st century: a comprehensive study across five European countries. Eur J Contracept Reprod Health Care. 2010;15 Suppl 2:S42–S53.
   Web of Science ®Google Scholar
• Szarewski A, Mansour D, Shulman LP. 50 years of “The Pill”: celebrating a golden anniversary. J Fam Plann Reprod Health Care. 2010;36(4):231–238.
   PubMedGoogle Scholar
• den Tonkelaar I, Oddens BJ. Preferred frequency and characteristics of menstrual bleeding in relation to reproductive status, oral contraceptive use, and hormone replacement therapy use. Contraception. 1999;59(6):357–362.
   PubMed Web of Science ®Google Scholar
• Klipping C, Duijkers I, Fortier MP, Marr J, Trummer D, Elliesen J. Long-term tolerability of ethinylestradiol 20 ag/drospirenone 3 mg in a flexible extended regimen: results from a randomised, controlled, multicentre study. J Fam Plann Reprod Health Care. 2012;38(2):84–93.
   PubMed Web of Science ®Google Scholar
• Klipping C, Duijkers I, Fortier MP, Marr J, Trummer D, Elliesen J. Contraceptive efficacy and tolerability of ethinylestradiol 20 jag/drospirenone 3 mg in a flexible extended regimen: an open-label, multicentre, randomised, controlled study. J Fam Plann Reprod Health Care. 2012;38(2):73–83.
   PubMed Web of Science ®Google Scholar
• Sulak PJ, Scow RD, Preece C, Riggs MW, Kuehl TJ. Hormone withdrawal symptoms in oral contraceptive users. Obstet Gynecol. 2000;95(2):261–266.
   PubMed Web of Science ®Google Scholar
• Archer DF. Menstrual-cycle-related symptoms: a review of the rationale for continuous use of oral contraceptives. Contraception. 2006;74(5):359–366.
   PubMed Web of Science ®Google Scholar
• Sulak PJ, Kaunitz AM, London AM, Moore AM, Nelson AL. Extended regimen oral contraceptives – practical management. J Fam Pract. 2007 2007:S1–S8.
   Google Scholar
• Archer DF, Kovalevsky G, Ballagh SA, Grubb GS. Ovarian activity and safety of a novel levonorgestrel/ethinyl estradiol continuous oral contraceptive regimen. Contraception. 2009;80(3):245–253.
   Web of Science ®Google Scholar
• Barnhart K, Mirkin S, Grubb G, Constantine G. Return to fertility after cessation of a continuous oral contraceptive. Fertil Steril. 2009;91(5):1654–1656.
   Web of Science ®Google Scholar
• Machado RB, de Melo NR, Maia H Jr, Cruz AM. Effect of a continuous regimen of contraceptive combination of ethinylestradiol and drospirenone on lipid, carbohydrate and coagulation profiles. Contraception. 2010;81(2):102–106.
   Web of Science ®Google Scholar
• Makuch MY, Duarte-Osis MJ, de Padua KS, Petta C, Bahamondes L. Opinion and experience of Brazilian women regarding menstrual bleeding and use of combined oral contraceptives. Int J Gynaecol Obstet. 2012;117(1):5–9.
   PubMed Web of Science ®Google Scholar
• Makuch MY, Osis MJ, Petta CA, de Padua KS, Bahamondes L. Menstrual bleeding: perspective of Brazilian women. Contraception. 2011;84(6):622–627.
   Web of Science ®Google Scholar
• Estanislau do Amaral MC, Hardy E, Hebling EM, Faundes A. Menstruation and amenorrhea: opinion of Brazilian women. Contraception. 2005;72(2):157–161.
   Web of Science ®Google Scholar
• Snow R, Hardy E, Kneuper E, Hebling EM, Hall G. Women’s responses to menses and nonbleeding intervals in the USA, Brazil and Germany. Contraception. 2007;76(1):23–29.
   PubMed Web of Science ®Google Scholar
• Hardy E, Hebling EM, de Sousa MH, Kneuper E, Snow R. Association between characteristics of current menses and preference for induced amenorrhea. Contraception. 2009;80(3):266–269.
   PubMed Web of Science ®Google Scholar